Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free

被引:57
|
作者
Wasserberg, N
Tulchinsky, H
Schachter, J
Feinmesser, M
Gutman, H
机构
[1] Tel Aviv Univ, Rabin Med Ctr, Dept Surg B, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Rabin Med Ctr, Dept Oncol, IL-49100 Petah Tiqwa, Israel
[4] Rabin Med Ctr, Dept Pathol, IL-49100 Petah Tiqwa, Israel
来源
EJSO | 2004年 / 30卷 / 08期
关键词
sentinel node; melanoma; complication; edema; wound; neuropathy; metastasis; prognosis;
D O I
10.1016/j.ejso.2004.06.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and aim. Sentinel lymph node biopsy (SLNB) is reportedly associated with insignificant morbidity. The study aims at documenting SLNB-related complications and identifying possible risk factors. Method. Data of all melanoma patients who underwent SLNB in our medical center (1994-2002) were analysed. Procedure-related complications were recorded. Results. Three hundred and nine lymphatic basins of 250 patients were explored for SLNB. Overall complication rate was 20%. Sensory morbidity was significantly associated with axillary SLNB (p=0.04) and was more prevalent in younger patients. The use of blue dye alone or combined with a hand-held gamma probe had no statistically significant impact on the identification rate. There were six false-negatives (2.3%), for an overall false-negative rate of 18%. A positive sentinel node was significantly associated with shortened overall survival (p=0.04). Conclusion. Wound complications are more frequent than usually reported. Sensory morbidity occurs mostly in the axilla. Neck SLNB is associated with the highest rate of identification failure. Patient age, basin location, and number of excised nodes may serve as prognostic factors of morbidity. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:851 / 856
页数:6
相关论文
共 50 条
  • [1] Sentinel-Lymph-Node Biopsy for Cutaneous Melanoma
    Nieweg, Omgo E.
    Veenstra, Hidde J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (06): : 570 - 570
  • [2] Sentinel-Lymph-Node Biopsy for Cutaneous Melanoma
    Gershenwald, Jeffrey E.
    Ross, Merrick I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (18): : 1738 - 1745
  • [3] Sentinel-Lymph-Node Biopsy for Cutaneous Melanoma REPLY
    Ross, Merrick I.
    Gershenwald, Jeffrey E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (06): : 571 - 571
  • [4] Sentinel Lymph Node Biopsy (SLNB) in Anorectal Melanoma
    Wainstein, A.
    Kansaon, M.
    Siqueira, R.
    Conceicao, S.
    Lacerda, L.
    Santos, F.
    Wainstein, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 85 - 85
  • [5] Sentinel-lymph-node biopsy
    McMasters, KM
    Edwards, MJ
    Ross, MI
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04): : 318 - 319
  • [6] Sentinel-lymph-node biopsy
    Koller, J
    Rettenbacher, L
    HAUTARZT, 2000, 51 (01): : 47 - 54
  • [7] Why perform sentinel-lymph-node biopsy in patients with melanoma?
    Steven A Rosenberg
    Nature Clinical Practice Oncology, 2008, 5 : 1 - 1
  • [8] The arguments against sentinel lymph node biopsy (SLNB) in melanoma
    Thomas, J. M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2011, 52 : 1 - 1
  • [9] Why perform sentinel-lymph-node biopsy in patients with melanoma?
    Rosenberg, Steven A.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (01): : 1 - 1
  • [10] Sentinel lymph node biopsy (SLNB) and ultrasound scanning in cutaneous melanoma
    Konstantinow, A
    SKIN AND ENVIRONMENT - PERCEPTION AND PROTECTION, VOLS 1 AND 2, 2001, : 1167 - 1173